[Gastric adenocarcinoma secondary to Hodgkin's disease treatment].
Second malignant neoplasms are a major cause of late morbidity and mortality following treatment for Hodgkin's disease. Gastric carcinoma belong to the rare secondary malignancies induced by radiation-therapy and it is associated with a poor prognosis. We report a patient treated for Hodgkin's disease by 6 ABVD and total lymphoid radiation therapy, who developed a gastric carcinoma 9 years after completing treatment. Our case fits the criteria for radiation induced malignancies reported from the literature:


CONCLUSIONS
recommendations are presented for both prevention and early detection of the tumours we recommend a strict follow-up for patients treated for HD to detect second cancers.
el Omri
H
H
Service d'Hématologie Clinique, CHU Farhat Hached de Sousse.
Sriha
B
B
Kraiem
I
I
Youssef
Y B
YB
Skouri
H
H
Korbi
S
S
Ennabli
S
S
D000230:Adenocarcinoma / Q000139:chemically induced* / Q000175:diagnosis / Q000209:etiology*; D000328:Adult; D000359:Aftercare / Q000379:methods; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001706:Biopsy; D001761:Bleomycin / Q000009:adverse effects*; D003606:Dacarbazine / Q000009:adverse effects*; D003680:Deglutition Disorders / Q000209:etiology; D004317:Doxorubicin / Q000009:adverse effects*; D017809:Fatal Outcome; D006689:Hodgkin Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D009381:Neoplasms, Radiation-Induced / Q000139:chemically induced* / Q000175:diagnosis / Q000209:etiology*; D016609:Neoplasms, Second Primary / Q000139:chemically induced* / Q000175:diagnosis / Q000209:etiology*; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects*; D013274:Stomach Neoplasms / Q000139:chemically induced* / Q000175:diagnosis / Q000209:etiology*; D014057:Tomography, X-Ray Computed; D014747:Vinblastine / Q000009:adverse effects*; D015431:Weight Loss
D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin
Adenocarcinome gastrique secondaire au traitement d'une maladie de Hodgkin.